These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30020560)

  • 1. Exploring the heterogeneity of MS lesions using positron emission tomography: a reappraisal of their contribution to disability.
    Stankoff B; Poirion E; Tonietto M; Bodini B
    Brain Pathol; 2018 Sep; 28(5):723-734. PubMed ID: 30020560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis.
    Bodini B; Poirion E; Tonietto M; Benoit C; Palladino R; Maillart E; Portera E; Battaglini M; Bera G; Kuhnast B; Louapre C; Bottlaender M; Stankoff B
    J Nucl Med; 2020 Jul; 61(7):1043-1049. PubMed ID: 32005777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Imaging of Immune Cell Dynamics During De- and Remyelination in the Cuprizone Model of Multiple Sclerosis by [
    Zinnhardt B; Belloy M; Fricke IB; Orije J; Guglielmetti C; Hermann S; Wagner S; Schäfers M; Van der Linden A; Jacobs AH
    Theranostics; 2019; 9(6):1523-1537. PubMed ID: 31037121
    [No Abstract]   [Full Text] [Related]  

  • 4. Predicting PET-derived myelin content from multisequence MRI for individual longitudinal analysis in multiple sclerosis.
    Wei W; Poirion E; Bodini B; Tonietto M; Durrleman S; Colliot O; Stankoff B; Ayache N
    Neuroimage; 2020 Dec; 223():117308. PubMed ID: 32889117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET in multiple sclerosis.
    Niccolini F; Su P; Politis M
    Clin Nucl Med; 2015 Jan; 40(1):e46-52. PubMed ID: 24561681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis.
    de Paula Faria D; Real CC; Estessi de Souza L; Teles Garcez A; Navarro Marques FL; Buchpiguel CA
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis.
    Ben-Shalom I; Karni A; Kolb H
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards molecular imaging of multiple sclerosis.
    Owen DR; Piccini P; Matthews PM
    Mult Scler; 2011 Mar; 17(3):262-72. PubMed ID: 21212087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
    Sucksdorff M; Matilainen M; Tuisku J; Polvinen E; Vuorimaa A; Rokka J; Nylund M; Rissanen E; Airas L
    Brain; 2020 Dec; 143(11):3318-3330. PubMed ID: 33006604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis.
    Beaino W; Janssen B; Kooij G; van der Pol SMA; van Het Hof B; van Horssen J; Windhorst AD; de Vries HE
    J Neuroinflammation; 2017 Dec; 14(1):259. PubMed ID: 29273052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study.
    Giannetti P; Politis M; Su P; Turkheimer F; Malik O; Keihaninejad S; Wu K; Reynolds R; Nicholas R; Piccini P
    Neurobiol Dis; 2014 May; 65():203-10. PubMed ID: 24508617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuronal component of gray matter damage in multiple sclerosis: A [(11) C]flumazenil positron emission tomography study.
    Freeman L; Garcia-Lorenzo D; Bottin L; Leroy C; Louapre C; Bodini B; Papeix C; Assouad R; Granger B; Tourbah A; Dollé F; Lubetzki C; Bottlaender M; Stankoff B
    Ann Neurol; 2015 Oct; 78(4):554-67. PubMed ID: 26292991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.
    Colasanti A; Guo Q; Muhlert N; Giannetti P; Onega M; Newbould RD; Ciccarelli O; Rison S; Thomas C; Nicholas R; Muraro PA; Malik O; Owen DR; Piccini P; Gunn RN; Rabiner EA; Matthews PM
    J Nucl Med; 2014 Jul; 55(7):1112-8. PubMed ID: 24904112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging Central Nervous System Demyelination and Remyelination by Positron-Emission Tomography.
    Bodini B; Stankoff B
    Brain Plast; 2016 Dec; 2(1):93-98. PubMed ID: 29765850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron Emission Tomography with [
    Hamzaoui M; Garcia J; Boffa G; Lazzarotto A; Absinta M; Ricigliano VAG; Soulier T; Tonietto M; Gervais P; Bissery A; Louapre C; Bottlaender M; Bodini B; Stankoff B
    Ann Neurol; 2023 Aug; 94(2):366-383. PubMed ID: 37039158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring Pathology in Patients with Multiple Sclerosis Using Positron Emission Tomography.
    Brier MR; Taha F
    Curr Neurol Neurosci Rep; 2023 Sep; 23(9):479-488. PubMed ID: 37418219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography imaging in evaluation of MS pathology in vivo.
    Högel H; Rissanen E; Vuorimaa A; Airas L
    Mult Scler; 2018 Oct; 24(11):1399-1412. PubMed ID: 30091657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.
    Absinta M; Sati P; Masuzzo F; Nair G; Sethi V; Kolb H; Ohayon J; Wu T; Cortese ICM; Reich DS
    JAMA Neurol; 2019 Dec; 76(12):1474-1483. PubMed ID: 31403674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study.
    Pitombeira MS; Koole M; Campanholo KR; Souza AM; Duran FLS; Solla DJF; Mendes MF; Pereira SLA; Rimkus CM; Busatto GF; Callegaro D; Buchpiguel CA; de Paula Faria D
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4551-4566. PubMed ID: 35838758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.
    de Paula Faria D; de Vries EF; Sijbesma JW; Dierckx RA; Buchpiguel CA; Copray S
    Neuroimage; 2014 Feb; 87():395-402. PubMed ID: 24188813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.